Black Rock Inc. Stoke Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,409,169 shares of STOK stock, worth $63.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,409,169

Previous 3,858,463 40.19%

Holding current value

$63.2 Million

Previous $52.1 Million 40.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $17.1 Million - $27.2 Million	1,550,706 Added 40.19%	5,409,169 $73.1 Million
Q1 2024 May 10, 2024	BUY	$4.12 - $14.17 $7.41 Million - $25.5 Million	1,798,231 Added 87.28%	3,858,463 $52.1 Million
Q4 2023 Feb 13, 2024	SELL	$3.37 - $5.4 $492,956 - $789,901	-146,278 Reduced 6.63%	2,060,232 $10.8 Million
Q3 2023 Nov 13, 2023	SELL	$3.78 - $11.99 $329,464 - $1.05 Million	-87,160 Reduced 3.8%	2,206,510 $8.69 Million
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $3.55 Million - $6.19 Million	448,175 Added 24.28%	2,293,670 $24.4 Million
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $113,587 - $154,122	14,848 Added 0.81%	1,845,495 $15.4 Million
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $872,749 - $1.94 Million	123,444 Added 7.23%	1,830,647 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $61,719 - $110,712	4,914 Added 0.29%	1,707,203 $21.9 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $2.9 Million - $6.7 Million	279,937 Added 19.68%	1,702,289 $22.5 Million
Q1 2022 May 12, 2022	SELL	$17.19 - $26.1 $1.03 Million - $1.56 Million	-59,913 Reduced 4.04%	1,422,352 $29.9 Million
Q4 2021 Feb 10, 2022	BUY	$18.11 - $30.72 $1.25 Million - $2.12 Million	69,147 Added 4.89%	1,482,265 $35.6 Million
Q3 2021 Nov 09, 2021	SELL	$23.65 - $34.44 $2.42 Million - $3.52 Million	-102,321 Reduced 6.75%	1,413,118 $35.9 Million
Q2 2021 Aug 11, 2021	BUY	$30.53 - $41.09 $46.3 Million - $62.3 Million	1,515,439 New	1,515,439 $51 Million

Others Institutions Holding STOK

# of Institutions

124

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $460M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account